Skip to content

TRIPHALADI GHANA VATI AND PATHYADI VARTI IN THE MANAGEMENT OF TIMIRA - CATARACT

â??EFFECT OF TRIPHALADI GHANA VATI ALONE AND ALONG WITH PATHYADI VARTI IN THE MANAGEMENT OF TIMIRA - IMMATURE SENILE CATARACT-AN OPEN LABEL TWO ARM RANDOMISED CONTROLLED TRIALâ??

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052165
Enrollment
126
Registered
2023-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H25- Age-related cataract

Interventions

None listed

Sponsors

ALL INDIA INSTITUTE OF AYURVEDA NEW DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having signs and symptoms of immature senile cataract described as per ayurvedic and contemporary texts. 2.Patients having cataract aged 40-60 years irrespective of sex, caste, religion. 3.Patients willing to undergo ayurvedic treatment. 4.Patients having visual acuity not less than 6/60 Snellen chart/Log MAR

Exclusion criteria

Exclusion criteria: 1.Patient not able to participate in the clinical trial. 2.Patient on local and systemic steroid medication. 3.Traumatic cataract and congenital cataract. 4.Patient having mature and hyper-mature senile cataract. 5.Patients suffering from inflammatory and infectious disease of eyeball and its appendages. 6.Patients having other systemic diseases or metabolic disorders such as uncontrolled diabetic mellitus, diabetic retinopathy, macular degeneration, retinitis pigmentosa and any other illness necessitating long term treatment or under any kind of immunosuppressive therapy. 7.Patient is under any kind of cataract inducing medications like corticosteroids, phenothiazines and miotics drugs etc. 8.History of any surgical intervention to eye

Design outcomes

Primary

MeasureTime frame
To compare improvement of vision in 90 days.Timepoint: 90 DYAS

Secondary

MeasureTime frame
â?¢ To compare improvement of other associated symptoms like glare, diplopia, black spots in front of eyes, difficulty in day and night vision, head ache.Timepoint: 90 DAYS

Countries

India

Contacts

Public ContactDr Manjusha Rajagopala

All India institute of Ayurveda, New Delhi

Hod-shalakya@aiia.gov.in8368303749

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026